– UK, London – Pathfinder Minerals Plc (LON: PFP) today announced the appointment of Jonathan Summers to its Board as an Independent Non-Executive Director effective immediately.
“I am delighted to welcome Jonathan Summers to the Board. His significant business experience will be beneficial to Pathfinder as we move into a new chapter of assessing additional opportunities for value creation, while continuing to advance our valuable Bilateral Investment Treaty claim.” said Board Chairman, Dennis Edmonds.
The Company also announced that John Taylor has stepped down from the Board with immediate effect.
Dennis Edmonds commented: “I would like to thank John Taylor for his contribution, both as Chief Executive Officer and latterly as a Non-Executive Director.”
About Jonathan Summers
Mr. Summers brings over 25 years of international business experience. He is a former Managing Director at Goldman Sachs, mainly in Europe, having spent 15 years at the firm from 1996 to 2011. He was Founding Partner and Head of Business Development for Everett Capital Advisors, a US$700 million London-based investment fund, and Founding Principal and Head of Business Development for Myriad Asset Management, a US$5 billion Hong Kong-based multi-strategy asset management firm. An active private investor in several fast-growing technology companies, Mr. Summers is currently the chairman of EXMceuticals Inc., a Canadian-listed medical cannabis company, as well as on the advisory board for Mocha Holdings LLC, a privacy-focused eCommerce business.
Mr. Summers holds a master’s degree in Modern History from the University of Oxford.
For more information: http://www.pathfinderminerals.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
